• The Risky Business of Drug Development- The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Development Journey – As Illustrated By The Decisions Of Germany' ...

    Nov 1, 2014, 00:00

  • A Budget Impact Analysis of Ustekinumab in the Management of Psoriatic Arthritis in Greece

    Nov 1, 2014, 00:00

  • Critical Appraisal Of Network Meta-Analyses Evaluating The Efficacy And Safety Of New Oral Anticoagulants In Atrial Fibrillation Stroke Prevention Trials

    Nov 1, 2014, 00:00

  • Patients' Preferences in Late Stage Treatment of Non-Small-Cell Lung Cancer- A Discrete-Choice Experiment

    Nov 1, 2014, 00:00

  • Predictors of Working Motivation in Job Satisfaction Among Nurses in Cyprus

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Multiple Anti-Osteoporotic Therapies for Secondary Fracture Prevention in Japan

    Nov 1, 2014, 00:00

  • A Payers Perspective to Pharmaceutical Market Access- Defining Market Access

    Nov 1, 2014, 00:00

  • Regional Assessment of Severe Hypoglycemic Coma Events in Finland

    Nov 1, 2014, 00:00

  • The Determinants of Uptake and Diffusion of Innovative Health Technologies. An Empirical Analysis

    Nov 1, 2014, 00:00

  • Study On The Direct Medical Cost of Malignant Neoplasms Inpatients With Urban Basic Health Insurance Scheme in China

    Nov 1, 2014, 00:00

  • Health-Related Quality Of Life Impact Of Triple Combinations Of Olmesartan Medoxomil, Amlodipine Besylate And Hydrochlorothiazide In Subjects With Hypertension

    Nov 1, 2014, 00:00

  • Adherence To Anticoagulant Therapy In Children Hospitalized for Pulmonary Embolism and Deep Vein Thrombosis

    Nov 1, 2014, 00:00

  • Real World Management and Costs in Unresectable Metastatic Melanoma (UMM) Patients Treated at the Antwerp University Hospital (UZA)

    Nov 1, 2014, 00:00

  • Translation And Cultural Adaptation Difficulties Encountered During Linguistic Validation Of The Bristol Stool Scale

    Nov 1, 2014, 00:00

  • Quality of Life in Patients Undergoing Hemodialysis- A Vision of the Influence of Time

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Analysis Tofacitinib Use in Rheumatoid Arthritis Treatment Scheme

    Nov 1, 2014, 00:00

  • Trends in Secondary Care Costs for Treatment of Head and Neck Cancer in England

    Nov 1, 2014, 00:00

  • Readmittance To Hospital Within 6 Months After A Venous Thromboembolism Event- Prefer In Vte Registry

    Nov 1, 2014, 00:00

  • Health-Related Quality of Life in Migraine Without Aura Based on Attack Frequency- A time Trade-Off Study

    Nov 1, 2014, 00:00

  • Outpatient Treatment of Adolescents in Japan with Drugs for Attention Deficit Disorders

    Nov 1, 2014, 00:00

  • Are Prices of Patent-Protected Pharamceuticals in the Top 5 Eu Countries Converging?

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis Of Ticagrelor Versus Generic Clopidogrel In The Treatment Of Patients With Acute Coronary Syndrome In Spain

    Nov 1, 2014, 00:00

  • The Endometriosis Health Profile (Ehp) – A Case Study of Successful Epro Collaboration

    Nov 1, 2014, 00:00

  • Acute Myeloid Leukemia and Myelodisplasic Syndrome Treated With Intensive Chemotherapy In France Based On National Hospital Databases (Pmsi)

    Nov 1, 2014, 00:00

  • A Systematic Review of Methods to Assess the Economic Impact of Air Pollution

    Nov 1, 2014, 00:00

  • Persistence in Health Expenditures by the Elderly in Taiwan- Predicting the Top 10% Users

    Nov 1, 2014, 00:00

  • Disability-Adjusted Life Years (Dalys) as a Composite Measure to Express the Burden of Tick-Borne Encephalitis (Tbe) in Slovenia

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Chronic Lumbosciatic Syndrome in the Slovak Republic

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Hypertensive Treatment With Indapamide And Amlodipine Single-Pill Combination In The Polish Setting

    Nov 1, 2014, 00:00

  • Use Of Computer Simulation To Generate Evidence To Aid Health Care Decision Making- An Example Using The Archimedes Model To Compare Rosuvastatin With Atorvastatin

    Nov 1, 2014, 00:00

  • Economic Assessment of Delaying Insulin Treatment Through The Use of Newer Anti-Diabetic Agents, Dapagliflozin (Forxiga®) And Exenatide (Bydureon®), Both As Add-On To Metformin; A Cost-Effectiveness Analysis From A Uk Nhs Perspective

    Nov 1, 2014, 00:00

  • Preliminary Assessment of the Cost of Treatment for Chronic Hepatitis C Virus Infections with Sofosbuvir and First Generation Antivirals Across Eight Countries

    Nov 1, 2014, 00:00

  • Long-Term Cost-Effectiveness Of Biphasic Human Insulin 30 In People With Type 2 Diabetes With Inadequate Glycaemic Control On Oral Antidiabetic Drugs In China

    Nov 1, 2014, 00:00

  • Towards Integration of Research Evidence on Patient Preferences in Coverage Decisions and Clinical Practice Guidelines- A Proposal for A Taxonomy of Preference-Related Terms

    Nov 1, 2014, 00:00

  • A Cost Of Care Model For Inflammatory Bowel Disease With A Uk Nhs Perspective

    Nov 1, 2014, 00:00

  • Epidemiology and Direct Health Care Costs of Diabetic Retinopathy- Results From a Population-Based Study

    Nov 1, 2014, 00:00

  • A Cost-Consequence Analysis of Human Papillomavirus Vaccination in Romania

    Nov 1, 2014, 00:00

  • High BMI and Belly fat Correlate with Prevalence of Hypertension And Diabetes- A Cross Sectional Study In Sedentary Urban Popultaion Of Delhi

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of the Original Drug Arglabin

    Nov 1, 2014, 00:00

  • Coverage With Evidence Development Activities Around The World- An Environment Scan

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Ranibizumab Versus Photodynamic Therapy for the Treatment of Neovascluar Age-Related Macular Degeneration Based in China Cost Setting

    Nov 1, 2014, 00:00

  • Quasi-Monte Carlo Simulation and Variance Reduction Techniques Substantially Reduce Computational Requirements of Patient-Level Simulation Models- an Application to a Discrete Event Simulation Model

    Nov 1, 2014, 00:00

  • A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database

    Nov 1, 2014, 00:00

  • Financial Implications to Taiwan Health System from Changing the Dialysis Modality Mix

    Nov 1, 2014, 00:00

  • Value in the Making- Harvesting the Value of Complex Medical Innovations in Practice

    Nov 1, 2014, 00:00

  • Cost-Effectiveness And Budget Impact Analyses Of Risk Stratification Of Patients With Moderate Risk Of Cardiovascular Events Using Lp-Pla2 Testing

    Nov 1, 2014, 00:00

  • A Cost-Utility Analysis of Sacral Anterior Root Stimulation (SARS) Compared to Medical Treatment in Complete Spinal Cord Injured Patients with a Neurological Bladder

    Nov 1, 2014, 00:00

  • The Benefit of Her-2 Targeted Therapies on Overall Survival of Patients With Metastatic Breast Cancer – A Systematic Review

    Nov 1, 2014, 00:00

  • How do Organizational Arrangements of the Pharmaceutical Supply System Affect Availability to Essential Medicines in Rural China?

    Nov 1, 2014, 00:00

  • Clinical and Demographics Characteristics of Non-Valvular Atrial Fibrillation Patients Switching From Warfarin To Novel Oral Anticoagulants

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis Of Antiviral Pharmacotherapies For Treatment Of Chronic Hepatitis C Virus Infection In Russia

    Nov 1, 2014, 00:00

  • Burden of Lupus Nephritis (Ln) Among Patients Managed In Routine Clinical Practices In Europe (Eu)

    Nov 1, 2014, 00:00

  • The Cost Burden of Community-Acquired Pneumonia in Russia in Adults of 50 and Older- A Regional Study and National Estimates

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Dabigatran Etexilate Compared With Warfarin And Rivaroxaban In The Treatment Of Acute Pulmonary Embolism In The Uk

    Nov 1, 2014, 00:00

  • Epidemiology of Multiple Sclerosis in Latin America- Critical Analysis of the Literature

    Nov 1, 2014, 00:00

  • Treatment Patterns and Health Care Costs in Patients with Schizophrenia Initiating with First- or Second-Generation Antipsychotic- Results from a Japanese Claims Database Analysis

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Crizotinib Treatment In Alk+ Non-Small-Cell Lung Cancer Patients In Thailand

    Nov 1, 2014, 00:00

  • The Economic Value of Vaccination- Why Prevention Is Wealth

    Nov 1, 2014, 00:00

  • Economic Burden of Melanoma in Three European Countries- A Retrospective Observational Study

    Nov 1, 2014, 00:00

  • Quality Assessment of Controlled Trials Evaluating Chinese Herbal Medicine in Patients With Rheumatoid Arthritis- A Systematic Review

    Nov 1, 2014, 00:00

  • The Benefits and Challenges of Submitting to the Nice Medical Technologies Evaluation Programme-Manufacturer Perceptions And Experiences

    Nov 1, 2014, 00:00

  • An Analysis of Us Medicare Beneficiaries- Burden of Direct Medical Costs in Patients With Idiopathic Pulmonary Fibrosis

    Nov 1, 2014, 00:00

  • Evaluating the Economic Burden and Health Care Utilizations of U. S. Veteran Patients Diagnosed with Chronic Hepatitis C

    Nov 1, 2014, 00:00

  • Cost Effectiveness Evaluation of Canagliflozin in Combination with Metformin and Sulfonylurea in Comparison To Nph Insulin in the Treatment of Type 2 Diabetes Mellitus In Poland

    Nov 1, 2014, 00:00

  • Can Using a Resource Use Log in an Economic Evaluation Alongside a Randomised Controlled Trial Reduce the Amount of Recall Bias?

    Nov 1, 2014, 00:00

  • Predictors of Adherence to Antidepressant Ýmedications in Saudi Arabia Ý

    Nov 1, 2014, 00:00

  • A Comparison of Additional Benefit Scores in Germany (Gba) and France (Has)

    Nov 1, 2014, 00:00

  • Image-Guided Navigation Systems (IGNS) Improve Accuracy of Catheter Placement in Shunted Hydrocephalus Patients

    Nov 1, 2014, 00:00

  • The Burden Of Chronic Urticaria In Europe- A Systematic Literature Review

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Economic Burden of Schizophrenia in China- Based on Medical Insurance Database from Guangzhou City

    Nov 1, 2014, 00:00

  • Health Care Utilization and Costs of Breast Cancer in the Medicaid Program

    Nov 1, 2014, 00:00

  • An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)

    Nov 1, 2014, 00:00

  • Survival Status in (Pharmaco) Epidemiological Studies can be Successfully Investigated Using Administrative Residential Registries

    Nov 1, 2014, 00:00

  • Value of Life And Cost of Pre-Mature Deaths With The Perspective Of Productivity As Net Tax Revenue- A Comparison In Argentina, Brazil And Mexico

    Nov 1, 2014, 00:00

  • Using Data Envelopment Analysis (Dea) To Rank Gp's According To Their P4p Quality and Efficiency Scores

    Nov 1, 2014, 00:00

  • Modification of Patient Reported Outcomes Measures of Compliance, Gastrointestinal Symptoms, Palatability and Treatment Satisfaction for Patients Needing Iron Chelation therapy

    Nov 1, 2014, 00:00

  • National Rare Disease Strategies- The Current State for Orphan Drug Market Access in European Union (Eu) Member States

    Nov 1, 2014, 00:00

  • (Cost-) Effectiveness of A Multi-Component Intervention for Adults With Epilepsy- Study Protocol of A Dutch Randomized Controlled Trial

    Nov 1, 2014, 00:00

  • Comparative Analysis of Pain Intensity in Hospice Care at Home and in Hospitals

    Nov 1, 2014, 00:00

  • Methods for Health Economic Evaluations of Vaccines – Results from an International Expert-Workshop

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Antiviral Therapy for Chronic Hepatitis B- A Systematic Review

    Nov 1, 2014, 00:00

  • Pharmaceutical Pricing and Market Competition- An Empirical Study Based on Anti-Infective Drugs In Tianjin, China

    Nov 1, 2014, 00:00

  • Baseline Patient Characteristics of A Prospective Observational Study to Evaluate the Care Map of Women With Postmenopausal Osteoporosis (Pmo) in Switzerland (Campos)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary – A Global Cost-Effectiveness Model Adaptation

    Nov 1, 2014, 00:00

  • Avoiding and Identifying Errors and Other Threats To the Credibility of Health Economic Models

    Nov 1, 2014, 00:00

  • The Move Towards Full Implementation Of The Nice Guidelines For Stroke Prevention In Atrial Fibrillation- The Potential Cost And Clinical Impact

    Nov 1, 2014, 00:00

  • Patient-Level Estimates of Diabetic Complications on Direct Medical Cost

    Nov 1, 2014, 00:00

  • Will Value Based Assessment (VBA) Revolutionise The Nice Assessment?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Colonic Stents for the Management of Malignant Large Bowel Obstruction

    Nov 1, 2014, 00:00

  • Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy for Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria (BG), Czech Republic (CZ) And Slovakia (SK) As Observe ...

    Nov 1, 2014, 00:00

  • Critical Assessment of Cost-Sharing Schemes Using a Simple Modeling Approach

    Nov 1, 2014, 00:00

  • Guidance For Economic Evaluation and Budget Impact Analysis For Pharmaceuticals in Catalonia (Spain)

    Nov 1, 2014, 00:00

  • Assessment of Medication Adherence in Rheumatoid Arthritis Patients in a Tertiary Care Hospital

    Nov 1, 2014, 00:00

  • Missing data Analysis in Longitudinal Studies- Findings from a Quality of Life Study in Malaysian Tuberculosis Patients

    Nov 1, 2014, 00:00

  • Evaluation of Social Welfare Part of Hungarian Drug Provision System

    Nov 1, 2014, 00:00

  • Reimbursement Decisions in Oncology Drugs- An International Analysis

    Nov 1, 2014, 00:00

  • Medication Counseling Beyond Instituitional- Impact Of Pharmacist-Led Home Medication Review In Type 2 Diabetes Patients

    Nov 1, 2014, 00:00

  • Biosimilars Versus Brands for Rheumatoid Arthritis- Eu5 Payers and Prescribers Place their Bets

    Nov 1, 2014, 00:00

  • Study of Medication Adherence in Diabetes Mellitus Patients with Hypertension

    Nov 1, 2014, 00:00

  • Predictive Modelling- Predicting Hospitalisation And Estimating The Cost And Risk To The Third Party Funder

    Nov 1, 2014, 00:00

  • Guidance for Risk Sharing Agreements / Pay Per- Results SCHEMES FOR PHARMACEUTICALS IN CATALONIA (SPAIN)

    Nov 1, 2014, 00:00

  • What Could the Future Hold? Simulating the Demand for Osteoarthritis (oa) Care in Alberta to Plan a Sustainable Oa Care System

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Lithium Versus an Atypical Anti-Psychotic (AAP) used to Augment Treatment with a Selective Serotonin Reuptake Inhibitor (SSRI) in Treatment Resistant Depression (TRD)

    Nov 1, 2014, 00:00

  • Financial and Clinical Implications of Intramuscular Versus Subcutaneous Interferon Beta-1a in Portugal, Based on the Findings from the Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Economic Evaluation of Home Parenteral Nutriton in Cancer Patients; The French Context

    Nov 1, 2014, 00:00

  • Diagnosing Anxiety Disorders in Primary Care- a Systematic Review and Meta-Analysis

    Nov 1, 2014, 00:00

  • Analysis of the Recent HTA Decision Making Landscape for Multiple Sclerosis Therapies – Trends and Future Opportunities

    Nov 1, 2014, 00:00

  • Ten Years Of Development Studies In Health Technology Assessment In Brazil- Profile Of Studies And Operational Indicators

    Nov 1, 2014, 00:00

  • Potentially Inappropriate Medication in the Elderly – Relevance and Economics of the 30 Top-Selling Priscus Agents in Germany

    Nov 1, 2014, 00:00

  • Impact Evaluation of Provider Payment Reform Under the New Rural Cooperative Medical Scheme in Gansu Province, China

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis Of Screening Strategies For Nonalcoholic Steatohepatitis

    Nov 1, 2014, 00:00

  • Measuring and Observing Positive And Negative Externalities Caused By Vaccines- Do We Have The Right Assessment Approach Available?

    Nov 1, 2014, 00:00

  • Assesment Of Serial Transverse Enteroplasty- Systematic Review

    Nov 1, 2014, 00:00

  • Factors Associated with Hospitalization of Type 2 Diabetic Patients with Hypoglycemic Episodes Assisted at Emergency Departments

    Nov 1, 2014, 00:00

  • The Effect of Procurement Design on Entry and Success of Generic Drug Firms

    Nov 1, 2014, 00:00

  • Knowledge of HIV Status of Adolescents and Young Adults Attending an Adolescent HIV Clinic in Accra, Ghana

    Nov 1, 2014, 00:00

  • UK Value-Based Assessment- Will Scotland's Smc Approach It In The Same Way?

    Nov 1, 2014, 00:00

  • A Health Technology-Related Cost Description Concerning Italian Ibd Centres Dealing With Crohn's Disease Results From Sole Study

    Nov 1, 2014, 00:00

  • Non-Steroidal Anti-Inflammatory Drugs in Household Drug Supplies in Serbia

    Nov 1, 2014, 00:00

  • Indirect Costs of Diabetes Mellitus (Dm) From the Perspective of The Social Insurance Institution (Zus) In Poland

    Nov 1, 2014, 00:00

  • Knowledge of Human Papillomavirus among University Students in Hungary

    Nov 1, 2014, 00:00

  • Real World Data (Rwd) At T=4 in the Netherlands

    Nov 1, 2014, 00:00

  • Hospitalization Costs Associated With Liver Cirrhosis

    Nov 1, 2014, 00:00

  • The Comparison of the Risk-Sharing Schemes Proposed in Reimbursement Applications Received By Ahtapol In 2012 and 2013

    Nov 1, 2014, 00:00

  • Ldl-C Lowering Efficacy of Evolocumab (Amg 145) Could Reduce Apheresis in Patients At High Risk for Cardiovascular Events in Germany

    Nov 1, 2014, 00:00

  • Dose-Response Network Meta-Analysis To Address Dose Heterogeneity In A Cost-Effectiveness Analysis In Acute Migraine

    Nov 1, 2014, 00:00

  • Quality of Life in Patients With Axial Spondyloarthritis in Clinical Practice In Sweden- Baseline Results From A Longitudinal Study

    Nov 1, 2014, 00:00

  • Understanding Caregiver Burden in Colorectal Cancer- What Role Do Patient And Carer Factors Play?

    Nov 1, 2014, 00:00

  • Do Specialty Drugs Offer Greater Value for Money Than Traditional Drugs?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Single-Pill Combination Therapy of Amlodipine/Atorvastatin Compared with Concurrent Two-Pill Therapy in Patients with Hypertension

    Nov 1, 2014, 00:00

  • Racial Disparities in Type 2 Diabetes Health Care Utilization in Medicaid Adults With Developmental Disabilities

    Nov 1, 2014, 00:00

  • A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases

    Nov 1, 2014, 00:00

  • Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies

    Nov 1, 2014, 00:00

  • A Comparative Clinical Evaluation of Trayodashanga Guggulu and Mustadiyapana Yoga Basti in Gridhrasi

    Nov 1, 2014, 00:00

  • Predictors For Mortality Among Human Immunodeficiency Virus Infected Patients On Antiretroviral Therapy

    Nov 1, 2014, 00:00

  • Risk of Bias in Trial-Based Economic Evaluations

    Nov 1, 2014, 00:00

  • Data Sources of Disease Epidemiology in German Drug Reimbursement Dossiers- Case Study Of Diabetes Mellitus Type II

    Nov 1, 2014, 00:00

  • Drug Utilization Research in Geriatric Patients with Chronic Ischemic Heart Disease

    Nov 1, 2014, 00:00

  • Self-Reported Health Related Quality Of Life Of Hepatitis C Virus (Hcv) Genotype 1 Patients With And Without Comorbid Conditions

    Nov 1, 2014, 00:00

  • A Budget Impact Analysis (Bia) Of The Use Of Paricalcitol For The Treatment Of Secondary Hyperparathyroidism (Shpt) In End Stage Renal Disease Patients

    Nov 1, 2014, 00:00

  • Economic Burden of Pediatric Atopic Dermatitis in Asia-Pacific- A Review of the Literature

    Nov 1, 2014, 00:00

  • Impact of Prior Authorization Restrictions on Resource Utilization and Costs In US Health Plans- A Review Of Literature

    Nov 1, 2014, 00:00

  • Systematic Review of Societal Cost of Illness Evidence in Patients With Psoriatic Arthritis

    Nov 1, 2014, 00:00

  • Prevalence of Chronic Diseases Among Older Patients (>65 Years) in German General Practitioner Practices

    Nov 1, 2014, 00:00

  • Inpatient Case-Related Treatment Costs For Different Cardiovascular Diseases In Germany

    Nov 1, 2014, 00:00

  • Retrospective Analysis of the Economic Burden of U. S. Long-Term Care Facility Residents Diagnosed with Parkinson's Disease

    Nov 1, 2014, 00:00

  • Prescribing Patterns of General Practitioners (Gps) in Primary Health Care- Evidence From Greece

    Nov 1, 2014, 00:00

  • Estimating Overall Impact of Human Papillomavirus Vaccination on Cervical Cancer Burden in Spain and Portugal

    Nov 1, 2014, 00:00

  • The Cost Comparison Of Drug-Eluting Stents (Des) And Bare-Metal Stents (Bms) - A Retrospective Cohort Matched Study

    Nov 1, 2014, 00:00

  • Cervical Human Papilloma Virus (HPV) DNA Primary Screening Test Results of the Experience of a Regional Laboratory in Central Italy

    Nov 1, 2014, 00:00

  • Drug Access Through Sharing Public And Individual Responsibilities In The Public Health Care System Of Singapore

    Nov 1, 2014, 00:00

  • Work Productivity Improvement Associated With Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results Of A Phase 3, Randomized, Controlled Trial

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Of High-Sensitive Troponin Assays For The Early Rule-Out Or Diagnosis Of Acute Myocardial Infarction (Ami) In People With Acute Chest Pain- A Nice Diagnostic Assessment

    Nov 1, 2014, 00:00

  • Estimating Utility Data for Patient Symptom Severity in Chronic Spontaneous Urticaria

    Nov 1, 2014, 00:00

  • A Kinematic Comparison of Overground and Treadmill Walking

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of 2-DOSE AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia

    Nov 1, 2014, 00:00

  • What is the Status of Health Related Quality of Life Among Medical Representatives in India?

    Nov 1, 2014, 00:00

  • Systematic Literature Review Assessing Data on the Burden of Allergic Rhinitis from a Cost and Quality of Life Perspective

    Nov 1, 2014, 00:00

  • Effectiveness of Heavy-Light Chain Quantitative Test- A Systematic Review

    Nov 1, 2014, 00:00

  • Estimation of Increased Costs in Switching from Tiotropium to Other Lama Therapy During Maintenance Treatment of COPD in the UK

    Nov 1, 2014, 00:00

  • Impact of 2011 German Health Care Reform on Prices

    Nov 1, 2014, 00:00

  • Cost Of Illness- Heart Failure In Ireland

    Nov 1, 2014, 00:00

  • An Ethic System Overview- Brazilian Perspectives For Observational Studies

    Nov 1, 2014, 00:00

  • The Epidemiologic Burden of Hepatitis C Virus Infection in Egypt

    Nov 1, 2014, 00:00

  • A Comparison of Factors Influencing Reimbursement and Coverage Decisions in Scotland (Smc), The Netherlands (Nzi) and Germany (G-Ba)

    Nov 1, 2014, 00:00

  • Incidence Of Unlicensed And Off-Label Prescription In Urologic Cancers Therapy In Turkey- Assessment Of Legislative And Regulatory Policy

    Nov 1, 2014, 00:00

  • A Model to Estimate the Health System Burden of Prescription Opioid Abuse in Europe

    Nov 1, 2014, 00:00

  • Translation and Linguistic Validation of Two COPD Symptom Diaries (Nicsi And Emsci) for Use in 14 Countries

    Nov 1, 2014, 00:00

  • Development And Content Validity Testing Of A Treatment Acceptance Measure For Use In Hypercholesterolemia Patients Receiving Treatment Via Subcutaneous Injection

    Nov 1, 2014, 00:00

  • Developing a Patient Centred Model for Clinicians to Individualise Cost Effective Treatment

    Nov 1, 2014, 00:00

  • Assessment Of The Huntington Quality Of Life Instrument (H-QOL-I) Cross-Cultural Validity

    Nov 1, 2014, 00:00

  • A Methodology for Estimating the Population of Advanced or Metastatic EGFR M+ Non-Small Cell Lung Cancer Patients in the UK and Ireland

    Nov 1, 2014, 00:00

  • Survey Findings on Evaluation of Traumatologist's Workload in Mongolia

    Nov 1, 2014, 00:00

  • Total Vaccine Cold Chain Volume Needed For Human Papillomavirus Vaccination In Bangladesh

    Nov 1, 2014, 00:00

  • The Lumley-Method, A Recommended Network Meta-Analysis for Indirect Comparisons, Summarized for Practitioners

    Nov 1, 2014, 00:00

  • Attitude Change Among 18-19 Years Old Boys After School-Drug Prevention Program

    Nov 1, 2014, 00:00

  • HTA Informed Price Negotiations- Cost Savings To The Health Payer in Ireland

    Nov 1, 2014, 00:00

  • Decision Drivers For Brazil- An Analysis of Conitec Recommendations

    Nov 1, 2014, 00:00

  • Setting Targets For Public Spending Under Eu-Imf Assistance To Portugal - The Case Of Health Care and Pharmaceuticals

    Nov 1, 2014, 00:00

  • How is Research and Development Innovation Evolving? Focus on Oncology and Cardiovascular Disease

    Nov 1, 2014, 00:00

  • Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in France

    Nov 1, 2014, 00:00

  • CANCER TREATMENT IN CHINA- HOW ARE POLICY AND PRACTICE IN TIER 1 VERSUS TIER 2/3 CITIES IMPACTING PATIENT ACCESS TO HIGH-COST THERAPIES

    Nov 1, 2014, 00:00

  • Drug Utilization Pattern for the Treatment of Septic Shock in the ICU- A Comparison Between Survivors and Non-Survivors in a Tertiary Care Teaching Institute

    Nov 1, 2014, 00:00

  • Community Pharmacist Perceptions of Generic Medicines- A Survey in Tehran

    Nov 1, 2014, 00:00

  • Health State In Patients With Venous Thromboembolism On Conventional And Non-Vka Oral Anticoagulants As Assessed With The Eq-5d-5l Questionnaire- Prefer In Vte Registry

    Nov 1, 2014, 00:00

  • Asthma Guideline Knowledge, Adherence and Cost of Treating Asthma at Emergency Department

    Nov 1, 2014, 00:00

  • Assessing The Relationship Between Individual Attributes Identified In Review Of Multi-Criteria Decision Analysis (MCDA) Of Rare Diseases And Annual Treatment Costs In Rare Endocrine Disorders

    Nov 1, 2014, 00:00

  • Working Ability and Monetarily Valued Productivity of Patients with Multiple Sclerosis Treated with Natalizumab

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Threshold For Orphan Designations in Poland Based on Reimbursement Decisions

    Nov 1, 2014, 00:00

  • Implementation of A Collaborative Pharmacy Practice Model in Nursing Homes of A Swiss Canton- Drug Cost Monitoring Between 2009 and 2012

    Nov 1, 2014, 00:00

  • Qualitative Assessment of the Quality of Pharmaceutical Care Services in the Province of Khyber Pakhtunkhwa, Pakistan- Hospital Pharmacists' Views

    Nov 1, 2014, 00:00

  • Identifying Consistent Inconsistency in Network Meta-Analyses - An Illustration In Type 2 Diabetes

    Nov 1, 2014, 00:00

  • Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also Known as Clostridium Difficile-Associated Diarrhoea (CDAD) in Spain

    Nov 1, 2014, 00:00

  • Factors Associated with Relocating to Nursing Homes Among Community-Dwelling Older Persons with Dementia

    Nov 1, 2014, 00:00

  • The Impact Of Diabetes On Mortality In Inpatients From Medical Department Of A Chinese Tertiary Hospital

    Nov 1, 2014, 00:00

  • The Intermediate Burden Of Diabetes Mellitus In Patients With Cardiovascular Disease (Cvd)- A Quality Adjusted Life Year (Qaly) -Analysis Based On Primary Longitudinal Data

    Nov 1, 2014, 00:00

  • Pharmaceutical Developpement- Africa an Emergent Market

    Nov 1, 2014, 00:00

  • Occurrence, Survival And Annual Cost of Colorectal-, Breast-, Prostate- and Lung Cancer in Hungary

    Nov 1, 2014, 00:00

  • Premixed Insulin Lispro Versus Insulin Glargine In Type 2 Diabetes- A Meta-Analysis

    Nov 1, 2014, 00:00

  • Effect of Vitamin E on the Vaginal Atrophy of Postmenopausal Women

    Nov 1, 2014, 00:00

  • Why Are There Differences In Hta Recommendations Across Countries? A Systematic Comparison of Hta Decision Processes for A Sample of Orphan Drugs In Four Countries

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Fingolimod in Relapsing Remitting Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Dose Titration, Persistence, and Adherence to Statin Therapy Among Patients with High-Risk Vascular Disease in Japan

    Nov 1, 2014, 00:00

  • Assessing the Relationship Between Patient Compliance to Blood Glucose Monitoring and Health Related Quality of Life

    Nov 1, 2014, 00:00

  • Pharmacoeconomic Assessment Of Apixaban Versus Standard Of Care For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation Patients

    Nov 1, 2014, 00:00

  • Budget Impact Analysis of Introducing Biosimilar Infliximab for the Treatment of Auto Immune Disorders In Five European Countries

    Nov 1, 2014, 00:00

  • A Cost Effectivness Analysis of Everolimus Compared with Axitinib in the Treatment of Metastatic Renal Cell Carcinoma in the United Kingdom

    Nov 1, 2014, 00:00

  • Encumberance to the Treatment of Osteoporosis- Physicians and Patient Perception

    Nov 1, 2014, 00:00

  • The Use Of Minimally Invasive Surgery (Mis) And Intraoperative Imaging Modalities In The Treatment Of Intracerebral Hemorrhage (Ich)- A Systematic Review Of The Literature

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Insulin Analogs Versus Human Insulin For Diabetes- A Systematic Review

    Nov 1, 2014, 00:00

  • Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets In Turkey

    Nov 1, 2014, 00:00

  • Towards a Framework for Analysing Sustainability of Economic Value- The Case of a Short Stay Programme for Breast Cancer Surgery Care Five Years After Implementation

    Nov 1, 2014, 00:00

  • Expert Elicitation Used for Early Technology Assessment to Inform on Cost-Effectiveness of Next Generation Sequencing

    Nov 1, 2014, 00:00

  • Questionnaire Analysis on Pharmacists Role and Drug Reimbursement List Adjustment Mechanism Under the Current China Health Insurance System

    Nov 1, 2014, 00:00

  • Health Related Quality of Life Among Young Smokers

    Nov 1, 2014, 00:00

  • Market Access for Medical Devices- Adapting to Change

    Nov 1, 2014, 00:00

  • Developing a Drug Price Reference Index in the Philippines

    Nov 1, 2014, 00:00

  • Quality of Life in Pregnant Women Attending Anti-Natal Clinics in Rural and Urban Areas of Delta State

    Nov 1, 2014, 00:00

  • Evaluation of the Economic Burden of Menopausal Women in the U. S. Medicaid Program

    Nov 1, 2014, 00:00

  • Cost Effectiveness Analysis of Everolimus + Exemestane for Patients with Advanced Breast Cancer with Positive Estrogen Receptor (ER +), HER2-, Refractory to Non-Steroidal Aromatase Inhibitors (NSAIS) in Chile

    Nov 1, 2014, 00:00

  • Recombinant Growth Hormone Therapy in Children with GH Deficiency- First Interventional Study in Armenia

    Nov 1, 2014, 00:00

  • Understanding the Japanese General Public's Rationale for Trades in a Time-Trade-Off Assessment for Systemic Lupus Erythematosus

    Nov 1, 2014, 00:00

  • A Systematic Review of Cost-Effectiveness Analysis of Cd4 Cell Count Verse Hiv Viral Load in Primarily Resource-Limited Setting

    Nov 1, 2014, 00:00

  • Analysis of Expenditure in Multiple Sclerosis Disease Modifying Therapies Evolution Between 2004-2013 in Spain

    Nov 1, 2014, 00:00

  • Cost of Best Supportive Care for Non-Small Cell Lung Cancer Patients – A German Perspective

    Nov 1, 2014, 00:00

  • The Potential Benefits of Long-Acting Atypical Antipsycothic Therapy in Preventing Relapse in Brazil

    Nov 1, 2014, 00:00

  • Comparison of Methods to Estimate Health State Utilities in Metastatic Breast Cancer (MBC)

    Nov 1, 2014, 00:00

  • Hye and me as Identical Currencies in Preference Studies? A Discrete-Choice Experiment in Type2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of the Therapy of Endometriosis

    Nov 1, 2014, 00:00

  • Cost and Burden of Non-Small Cell Lung Cancer's in Portugal

    Nov 1, 2014, 00:00

  • Quality of Life in Patients with Multiple Myeloma in Slovakia

    Nov 1, 2014, 00:00

  • Assessment of Effect of Continuous Subcutaneous Insulin Infusion Treatment, Insulin Analog And Human Insulin of Children With Diabetes

    Nov 1, 2014, 00:00

  • The Effectiveness of First Trimester Combined Screening on Reducing the Rate of Invasive Genetic Procedures in a City Based Population of Hungary 2010-2013

    Nov 1, 2014, 00:00

  • The Management of Irritable Bowel Syndrome (Ibs) in England- A Real World Study in Primary Care Clinical Practice

    Nov 1, 2014, 00:00

  • Estimating The Costs Of Specialist Out-Patient Services In A Public Hospital

    Nov 1, 2014, 00:00

  • Dental Care Use And Associated Factors Among People With Rheumatoid Arthritis- A Nationwide, Population-Based, Propensity Score-Matched Follow-Up Study

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Exenatide Bid Versus Insulin Lispro Tid As Add-On Therapy to Titrated Insulin Glargine in Patients With Type 2 Diabetes – An Analysis From The Swedish Health Care Perspective

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Celecoxib In the Treatment of Patients With Chronic Pain In Japan

    Nov 1, 2014, 00:00

  • Cost of Severe Hypoglycaemia in Hospitalized Patients In Poland- Is It Financed and Reported in a Right Way?

    Nov 1, 2014, 00:00

  • Pill Burden, Health Care Resource Utilization and Costs Among Subpopulations of Immediate Release Hydrocodone Users

    Nov 1, 2014, 00:00

  • Prevalence of Severe Treatment Resistant Hypertension and Eligibility for Catheter-Based Renal Denervation in Australia – a Preliminary Analysis

    Nov 1, 2014, 00:00

  • The Differences Between Infectious Parasitic Drug Approvals in Japan and the USA

    Nov 1, 2014, 00:00

  • Disutility Associated With Erectile Dysfunction in the Middle-Aged Or Older Males

    Nov 1, 2014, 00:00

  • Cost Effectiveness of Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis

    Nov 1, 2014, 00:00

  • Multiple Decision Criteria for Assessing An Incremental Cost-Effectiveness Ratio of Expensive Health Technologies

    Nov 1, 2014, 00:00

  • Economic Evaluation of Axitinib for Second Line Treatment in Adult Patients with Advanced Renal Cell Carcinoma – the Portuguese Case

    Nov 1, 2014, 00:00

  • Integration of Cost–Effectiveness Assessment in the Market Access Scheme of Drugs and Medical Devices In France

    Nov 1, 2014, 00:00

  • IMTA Productivity Cost Questionnaire (IPCQ)

    Nov 1, 2014, 00:00

  • Sensitivity Of The Safuca Questionnaire To Detect Differences Between Atrial Fibrillation Patients Treated With Vitamin-K Antagonist Against Those Treated With New Oral Anticoagulants

    Nov 1, 2014, 00:00

  • Costs Related to Pneumonia, Meningitis and Sepsis in Patients 50 Years and Older from the Private Health System Perspective in Brazil

    Nov 1, 2014, 00:00

  • A DE-NOVO Model to Predict Outcomes of a New Hypothetical Intervention to Reduce CV Risk in Post Mi Patients

    Nov 1, 2014, 00:00

  • Evidence for Validity of a National Physician and Patient-Reported Survey in China and United Kingdom- The Disease Specific Programme

    Nov 1, 2014, 00:00

  • Lubiprostone In Chronic Idiopathic Constipation- A Cost-Effectiveness Analysis

    Nov 1, 2014, 00:00

  • Implications for Time Savings Using New Intraoperative Measuring Technology

    Nov 1, 2014, 00:00

  • Boosting Biosimilars Uptake in European Countries

    Nov 1, 2014, 00:00

  • Using Health Assessment Questionnaire – Disability Index To Estimate Eq-5d Utility Values for Patients With Rheumatoid Arthritis in Taiwan

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Recommended Ranibizumab Regimen for Age-Related Macular Degeneration in China

    Nov 1, 2014, 00:00

  • Pain Therapy for Osteoarthritis in Germany- Analysis of Sickness Fund Claims Data

    Nov 1, 2014, 00:00

  • Demographics And Health Outcomes Associated With Adherence And Non-Adherence Among Type2 Diabetics In China

    Nov 1, 2014, 00:00

  • Incidence Description and Costs of Acute Heart Failure in the Netherlands

    Nov 1, 2014, 00:00

  • A Comparison of the Impact of Rheumatic Diseases and Other Chronic Diseases on Early Retirement in Portugal

    Nov 1, 2014, 00:00

  • Does Not Reaching an Agreement on the Final Nice Scope Have Any Impact on The Final Apraisal Outcome?

    Nov 1, 2014, 00:00

  • German Patients' Preferences for Attributes Of Type 2 Diabetes Medications

    Nov 1, 2014, 00:00

  • A Systematic Search and Methodological Review of Economic Models of Analgesics for Chronic Pain

    Nov 1, 2014, 00:00

  • Pharmacoeconomics and its Applications – Emerging Role in India

    Nov 1, 2014, 00:00

  • Understanding the Payer Dilemma with Biosimilar Mabs- Striking the Right Balance Between Budget Needs and Patient Outcomes

    Nov 1, 2014, 00:00

  • Economic Evaluation of Agomelatine for Major Depressive Disorders Relative to other Antidepressants in the Italian Setting

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of a Shingles Vaccination Program to Prevent Herpes Zoster And Post- Herpetic Neuralgia in the Spanish Setting

    Nov 1, 2014, 00:00

  • Application of Threshold Value for Cost-Effectiveness in Recommendations Issued by Agency for Health Technology Assessment in Poland for Cancer Drug Technologies

    Nov 1, 2014, 00:00

  • Systematic Review of the Economics of Multiple Sclerosis in Latin America

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Tocilizumab Verse Infliximab for the Patients With Rheumatoid Arthritis in Kazakhstan

    Nov 1, 2014, 00:00

  • Applying Multiple Criteria Decision Analysis in the Context of Health Technology Assessement- an Empirical Case Study

    Nov 1, 2014, 00:00

  • A Comaprative Cross-Sectional Study On Health-Related Quality Of Life In Psoriasis From Hungary And Iran

    Nov 1, 2014, 00:00

  • Health Care Utilization and Costs of Medicaid Program Services for Patients Diagnosed with Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Hta Epidemiology Data in Different Geographical Regions- Investigation of Requirements For Oncology Drugs

    Nov 1, 2014, 00:00

  • ESTIMATED ECONOMIC BURDEN OF INSULIN INJECTION-RELATED LIPOHYPERTROPHY IN CHINESE PATIENTS WITH DIABETES

    Nov 1, 2014, 00:00

  • Psychometric Evaluation of the Hypoglycaemia Perspectives Questionnaire in Patients With Type 2 Diabetes Mellitus

    Nov 1, 2014, 00:00

  • Direct and Indirect Costs Associated With Increasing Body Mass Index (Bmi) In the Eu5

    Nov 1, 2014, 00:00

  • Development of a Longitudinal National Football League Injury and Injury Impacts (L-NFL-III) Database

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Lenalidomide-Plus-Dexamethasone in Multiple Myeloma Patients Who Have Received at Least One Prior Therapy- A South Korean Perspective

    Nov 1, 2014, 00:00

  • Frequency of Outpatient Physiotherapy Services in Neurology Diseases in Hungary

    Nov 1, 2014, 00:00

  • Patients' Priorities in the Treatment of Neuroendocrine Tumors- An Analytic Hierarchy Process

    Nov 1, 2014, 00:00

  • Differences Between Hypothetical and Experience-Based Value Sets for Eq-5d- Implications for Decision Makers

    Nov 1, 2014, 00:00

  • Patient-Reported Outcomes of Dipeptidyl Peptidase-4 Inhibitors- A Systematic Review

    Nov 1, 2014, 00:00

  • Inclusion and Consideration of Patient Preferences in Amnog Early Benefit Assessments

    Nov 1, 2014, 00:00

  • Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany

    Nov 1, 2014, 00:00

  • Multi-Criteria Decision Analysis for Reimbursing Orphan Drugs- A Dutch Demonstration Study Using the Analytic Hierarchy Process Method

    Nov 1, 2014, 00:00

  • Evaluating Rates of Potential Generic Substitution for Prescription Drugs- Can We Improve On Existing Incentive Schemes?

    Nov 1, 2014, 00:00

  • Long Term Survival of Patients with Various Lung Cancer Histology in Seer Between 2004-2011

    Nov 1, 2014, 00:00

  • Chronic Care Management

    Nov 1, 2014, 00:00

  • Quality of Life and the Predictors of Thai Depressive Disorders Patients

    Nov 1, 2014, 00:00

  • A Potential Gender Bias in the Quality of Life - an Exploratory Standard Gamble Experiment Among Economics Students

    Nov 1, 2014, 00:00

  • Coverage Decision Framework in Asia Pacific- A Case Study of Targeted Cancer Medicines in the Treatment of Breast Cancer

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Theintroduction of A National Adherence Program for Type 2 Diabetes In Hungary

    Nov 1, 2014, 00:00

  • Nursing Diagnosis and Some Physiological Signs and Their Changes During the Arterial Hypertension

    Nov 1, 2014, 00:00

  • External Reference Pricing Impact of the Integration of the Amnog Discount In The List Price

    Nov 1, 2014, 00:00

  • Systematic Review of Economic Evaluations in Cancerology In Brazil Between 1980 And 2013

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation

    Nov 1, 2014, 00:00

  • Physicians Estimation Regarding The Impact Of Recession on Patient Adherence To Treatment In Diabetes Type 2 In Greece

    Nov 1, 2014, 00:00

  • Economic Implications Of Chronic Renal Disease With And Without Co-Morbid Diabetes In China, Post-2005

    Nov 1, 2014, 00:00

  • Impact of Caregiving for Patients with Alzheimer's Disease and Dementia on Psychiatric and Clinical Comorbidities in Brazil

    Nov 1, 2014, 00:00

  • Components of Sustainable Health Systems- What Is Known About The Cost-Effectiveness of Clinical Care?

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis of Protease Inhibitor Monotherapy Verse Ongoing Triple-Therapy in the Long-Term Management of HIV Patients

    Nov 1, 2014, 00:00

  • Economic Evaluetion of Fulvestrant 500 MG (F500) Versus Original Nonsteroidal Aromatase Inhibitors in Patient with Advanced Breast Canser in Russia (2 LINE THERAPY)

    Nov 1, 2014, 00:00

  • A Database Study to Investigate the Incidence of Anaphylaxis and the Prescription Rate of Self-Injection Epinephrine in Japan

    Nov 1, 2014, 00:00

  • Incidence and Risk of Cardiotoxicity Induced by Sunitinib in Patients with Renal Cell Carcinoma- A Population-Based Case-Control Study in Chinese Population

    Nov 1, 2014, 00:00

  • A Database Analysis Of Patients Eligible For Second-Line Lipid-Lowering Treatment For Hypercholesterolaemia In England

    Nov 1, 2014, 00:00

  • A Cost Comparison Analysis Of Medtronic's Stent Graft System To Competition For Endovascular Aneurysm Repair For Abdominal Aortic Aneurysms

    Nov 1, 2014, 00:00

  • Simulation of An Additional Go/No-Go Efficacy Interim Analysis in A Head-To-Head Rct

    Nov 1, 2014, 00:00

  • The Impact of Drug Policy on the Utilization of Medicines for Treatment of Cardiovascular Diseases in Slovak Republic

    Nov 1, 2014, 00:00

  • Selection of Topics For Nice Technology Appraisal 2005-2011- What Matters Most?

    Nov 1, 2014, 00:00

  • Real World Incidences And Hospital Cost Of Venous And Pulmonary Thromboembolic Events In France

    Nov 1, 2014, 00:00

  • Trends In Clinical Drug Development Timeframes, 1981-2013 – An Example From Virology

    Nov 1, 2014, 00:00

  • Knowledge on Medication Taking Behaviour, Balanced Diet and Physical Activity - A Survey Among the Adolescents

    Nov 1, 2014, 00:00

  • Economic Evaluation of Bevacizumab Versus Ranibizumab in Neovascular Age-Related Macular Degeneration in China

    Nov 1, 2014, 00:00

  • An Analysis of Quality of Care in the Respiratory Care Center Based on Services Provided by Physicians with Different Responsibilities and Specialties

    Nov 1, 2014, 00:00

  • An Analysis of the 2014 Moroccan Drug Price Cuts

    Nov 1, 2014, 00:00

  • Management of Crises and Risks in German Hospitals - Factors Influencing Medication Errors

    Nov 1, 2014, 00:00

  • Patterns of Asthma Treatment Utilization in Newly Diagnosed Elderly Patients are Inconsistent With Asthma Management Guidelines

    Nov 1, 2014, 00:00

  • Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System

    Nov 1, 2014, 00:00

  • Do new cancer drugs offer good value for money? the perspective of oncologists, payers, patients, and general population

    Nov 1, 2014, 00:00

  • Current Management and Barriers to Treatment for Wet Age-Related Macular Degeneration (Wamd)- Perspectives From Patients and Caregivers

    Nov 1, 2014, 00:00

  • Quality Of Life in Teenagers and Young Adolescent Patients With Diabetes Mellitus Type I With Insulin Pens Or Insulin Pumps In The Czech Republic

    Nov 1, 2014, 00:00

  • Cic Users' Preference For Catheters Reducing The Uti Frequency

    Nov 1, 2014, 00:00

  • Hipos-ER (Hypoglycemia in Portugal Observational Study – Emergency Room)- Clinical Outcomes in the Emergency Room

    Nov 1, 2014, 00:00

  • Cost-Benefit-Analysis of a Targeted Hospital Wide Pcr-Based Admission Screening for Mrsa in a German University Hospital – Consideration of a Six-Year Time Period

    Nov 1, 2014, 00:00

  • Preventing the Progression to Type 2 Diabetes Mellitus in Adults at High Risk- A Systematic Review And Network Meta-Analysis of Lifestyle, Pharmacological and Surgical Interventions

    Nov 1, 2014, 00:00

  • Evaluating The Gap Between Physicians' And Patients' Understanding Of Patient Needs

    Nov 1, 2014, 00:00

  • Results and implications of using a new eq-5d value set for cost-utility analyses in sweden. An application using enzalutamide (xtandi®) verse best supportive care for treatment of metastatic castration resistant prostate cancer (MCRPC)

    Nov 1, 2014, 00:00

  • The Differences Between Cancer Drug Approvals in Japan and the USA

    Nov 1, 2014, 00:00

  • Histoculture Drug Response Assay in Colorectal Cancer

    Nov 1, 2014, 00:00

  • The Effect of Degressive Financing Method on the Hungarian Drg Based Hospital Reimbursement Between 2011-2013

    Nov 1, 2014, 00:00

  • Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing Insulin

    Nov 1, 2014, 00:00

  • Launching Novel Class Iii Implantable Cardiac Devices for Cardiology in Europe First, Is This Common Commercial Practice Improving Health Care Quality for Europeans

    Nov 1, 2014, 00:00

  • The Oncology Pain Treatment Clinical Studies Quality Assessment

    Nov 1, 2014, 00:00

  • Annual Cost Of Conservative Treatment Of Supraventricular Tachycardias In Poland

    Nov 1, 2014, 00:00

  • Benefit Of Positive Airway Pressure (Pap) Therapy In Sleep Apnoea (Sa) Patients With Type Ii Diabetes Mellitus (T2dm) In Germany- A Retrospective Comparative Cohort Analysis Based On A Statutory Health Insurance Database

    Nov 1, 2014, 00:00

  • Whatever Happened To Nice Value-Based Pricing? Welcome, Value-Based Assessment

    Nov 1, 2014, 00:00

  • Survival After Locoregional Recurrence or Second Primary Breast Cancer- Impact of the Disease-Free Interval

    Nov 1, 2014, 00:00

  • A Retrospective Cohort Study of Risk Factors for Death Among Humman Immunodeficiency Virus Infected Adult Patients

    Nov 1, 2014, 00:00

  • Comparison of a Markov Cohort Model and a Discrete-Event Simulation for Economic Analyses of Treatments for Multiple Sclerosis

    Nov 1, 2014, 00:00

  • Patient-Reported Fall Related Health Care Services in Elderly Women

    Nov 1, 2014, 00:00

  • Impact of Morbidity in Populations of North London Clinical Commissioning Groups on Patient Admission Rates and Gp Referrals

    Nov 1, 2014, 00:00

  • Assessing Balance in Baseline Characteristics Using Different Propensity Adjusted Methods for Bipolar I Mixed Disorder Patients Initiating Asenapine Versus Other Oral Atypical Antipsychotics

    Nov 1, 2014, 00:00

  • Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries

    Nov 1, 2014, 00:00

  • Simvastatin Plus Fenofibrate As A Fixed Dose Combination In The Treatment Of Mixed Dyslipidemia In Gree Budget Impact Analysis

    Nov 1, 2014, 00:00

  • In Vitro Drug Release and Ex Vivo Permeation Study of Prepared Mouth Dissolving Tablets of Fluconazole Through Porcine Buccal Mucosa

    Nov 1, 2014, 00:00

  • Hta Studies On Orphan Drugs By Rebratsxmembers

    Nov 1, 2014, 00:00

  • Cost and Burden Of Hypercholesterolemia In Portugal

    Nov 1, 2014, 00:00

  • Progression of Physiological Parameters Over Time in Type 1 Diabetes Mellitus Patients in France

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Posaconazole Versus Fluconazole or Itraconazole in the Prophylaxis of Invasive Fungal Infections Among Neutropenic Patients in Thailand

    Nov 1, 2014, 00:00

  • From Regulatory Approval to Subsidised Patient Access in the Asia-Pacific Region- A Comparison of Systems Across Australia, China, Japan, Korea, New Zealand, Taiwan And Thailand

    Nov 1, 2014, 00:00

  • Antidepressant use and Suicide Rate in England- the Geographic Divide

    Nov 1, 2014, 00:00

  • The Incidence Of Upper And Lower Gastrointestinal Complications- A Retrospective Study Using A Japanese Health Care Database

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Celecoxib and Non Selective Non Steroidal Anti-Inflammatory Drug (Nsaid) Therapy for the Treatment of Osteoarthritis in Spain- A Decision-Tree Model

    Nov 1, 2014, 00:00

  • Clinical Pathway And Health Care Resources Utilization Of A Patients Cohort At High Risk Of Cardiovascular Disease Of Local Health Care Unit (Asln°1) Of Milan- A Results Of Intervention On Secondary Prevention

    Nov 1, 2014, 00:00

  • Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia- Results from a Markov Model

    Nov 1, 2014, 00:00

  • Influenza Vaccination In Japan Among The General Population And High-Risk Groups

    Nov 1, 2014, 00:00

  • Persistence in Open and Closed Data Sources- A Study of Fingolimod Verse Interferons/Glatiramer Acetate in Patients with Multiple Sclerosis

    Nov 1, 2014, 00:00

  • HTA Approach in Italy. Structure, Methods, And Process Of Veneto Region's Evaluation Of Pharmaceutical Effectiveness Unit (Unità Di Valutazione Dell'efficacia Del Farmaco, Uvef)

    Nov 1, 2014, 00:00

  • Cost-Effectiveness Analysis Of An Antimicrobial Transparent Dressing For Protecting Central Vascular Accesses In Critically Ill Patients Versus Standard Transparent Dressings In Fran A Comparison Of Two Modeling Approaches- Decision-Tree Ve ...

    Nov 1, 2014, 00:00

  • Preferences of Spanish Patients Over the Attributes of Biological Agents for the Treatment of Rheumatic Diseases Depending On the Administration Route

    Nov 1, 2014, 00:00

  • Belimumab for the Treatment of Systemic Lupus Erythematosus (Sle) In Gree A Cost-Effectiveness and Cost-Utility Analysis

    Nov 1, 2014, 00:00

  • Drug Utilization Review of Acid Suppressants (Durable) – an Audit to Assess the Utilization of Proton Pump Inhibitors and Histamine H2-Receptor Antagonists in Canadian Hospitals

    Nov 1, 2014, 00:00

  • Efficacy of Treatments for Macular Oedema Secondary to Branch Retinal Vein Occlusion- A Network Meta-Analysis

    Nov 1, 2014, 00:00

  • Hierarchical Network Meta-Analysis Incorporating Ordering Constraints on Increasing Doses of Interventions - Application to Overactive Bladder Syndrome

    Nov 1, 2014, 00:00

  • Microsimulation Model For The Assessment Of Personalized Cancer Care- The Mapcca Model Framework

    Nov 1, 2014, 00:00

  • How Likely Warfarin Pharmacogenetic Test to be Cost-Effective in Thailand- A Threshold Analysis

    Nov 1, 2014, 00:00

  • Qaly Weightings Based on the Burden of Illness Applied to a Uk Cost-Effectiveness Analysis of Nab-Paclitaxel + Gemcitabine Versus Gemcitabine Alone for the Treatment of Metastatic Pancreatic Cancer

    Nov 1, 2014, 00:00

  • ARE TOTAL HEALTH CARE EXPENDITURES IMPACTED BY A NEW DIABETES DIAGNOSTIC FACTOR- HBA1C?

    Nov 1, 2014, 00:00

  • The Cost-Effectiveness of Different Scenarios of Detecting of TB Among HIV-Infected People Depending on CD 4+ Count

    Nov 1, 2014, 00:00

  • Effects and Safety of Ceftriaxone Versus Levofloxacin in Treating Community-Acquired Pneumonia- A Sysytematic Review

    Nov 1, 2014, 00:00

  • Evaluation of The Impact of Pharmaceutical Cognitive Service on Quality of Life in Diabetic Patients

    Nov 1, 2014, 00:00

  • Costs Per Successfully Treated Patient with Sofosbuvir in GT1 HCV

    Nov 1, 2014, 00:00

  • Regulatory Issues in Pro Advertising- A Review of the Ddmac/Opdp Letters From 1998 To 2013 To Identify Pro Claims Violations and Examine Their Evolution Over Time

    Nov 1, 2014, 00:00

  • A Cost-Effectiveness Analysis Of Onabotulinumtoxina Verse. Best Supportive Care (bsc) For The Treatment Of Anticholinergic Treatment-Refractory Neurogenic Detrusor Overactivity (ndo)

    Nov 1, 2014, 00:00

  • When It May Not Be Necessary To Model Overall Survival for Economic Evaluations of Anti-Cancer Drugs

    Nov 1, 2014, 00:00

  • The Efficacy of Oximes in Acute Human Organophosphorus Poisoning; An Updated Meta-Analysis

    Nov 1, 2014, 00:00

  • Health Care use and Oral Medication Patterns for Type 2 Diabetes Patiets in China：The Role of Traditional Chinese Medicines

    Nov 1, 2014, 00:00

  • Economic Evaluation Of Percent Free Psa For Prostate Cancer Detection In Taiwanese Men

    Nov 1, 2014, 00:00

  • Long-Term Work Productivity Costs Among Subjects With Early Rheumatoid Arthritis - A Nationwide Analysis Based on 7,831 Subjects' Sickness Absence Days and Income

    Nov 1, 2014, 00:00

  • Are Cycles Needed in Markov Models? – The Continuous Model as a Simpler Approach

    Nov 1, 2014, 00:00

  • Cost-Utility Analysis of Dolutegravir Compared to Raltegravir in Treatment Naive and Treatment Experienced Patients in Slovak Settings

    Nov 1, 2014, 00:00

  • Examining the Economic Benefits of Lifestyle Intervention in Segments of A Prediabetic Population

    Nov 1, 2014, 00:00

  • Measuring Extent of Access For Nice Health Technology Assessment Decisions- Trends From 2008 to 2013

    Nov 1, 2014, 00:00

  • Survey of Treatment Costs to Hepatitis C in China

    Nov 1, 2014, 00:00

  • Awareness of Hyperlipidemia Among University Students and Staff Member

    Nov 1, 2014, 00:00

  • Comparison of Health Care Resource use and Costs in Patients with Opioid Prescription Drug Dependence (Opd) Treated with Buprenorphine/Naloxone and Patients without Pharmacological Treatment- Retrospective Analysis of us Public Insurance Cl ...

    Nov 1, 2014, 00:00

  • The Impact of Discrimination, Victimization and Social Standing on Health-Related Quality of Life

    Nov 1, 2014, 00:00

  • Comparison of Clinical Characteristics of Patients With Rheumatoid Arthritis (Ra) Receiving Biologic Monotherapy and Biologic-Containing Combination Therapy in Europe

    Nov 1, 2014, 00:00

  • The Medical Costs of Chronic Obstructive Pulmonary Disease in South Korea

    Nov 1, 2014, 00:00

  • Impact of Generic Substitution On the Prescribing of Meprobamate-Containing Combination Analgesics In South Africa

    Nov 1, 2014, 00:00

  • Modeling the Effect of Combining Alogliptin With Dual therapy in Type 2 Diabetes

    Nov 1, 2014, 00:00

  • Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA Agencies

    Nov 1, 2014, 00:00

  • Comparative Effectiveness Research of Medical Devices – New Methods Needed?

    Nov 1, 2014, 00:00

  • Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil

    Nov 1, 2014, 00:00

  • Rates of Diagnosed Opioid Abuse Or Dependence and Incremental Direct Health Care Costs Among Patients With Long-Term Use of Immediate Release Hydrocodone

    Nov 1, 2014, 00:00

  • Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-On To Metformin And Sulfonilurea (Met+Su) Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) in Patients with Type 2 Diabetes Mellit ...

    Nov 1, 2014, 00:00

  • A Systematic Review of Health State Utility Values for Advanced Ovarian Cancer

    Nov 1, 2014, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109 (current)
  • 110
  • »